Alpine

Alpine Bank announces changes to its Board of Directors

Retrieved on: 
Thursday, April 11, 2024
Thought, Digital, Colorado River, Alicja Kornasiewicz, Karow, Alpine, Accounting

“We thank and honor John, Stan, Bruce, and Dave for their service to the bank and our communities,” said Glen Jammaron, president of Alpine Bank.

Key Points: 
  • “We thank and honor John, Stan, Bruce, and Dave for their service to the bank and our communities,” said Glen Jammaron, president of Alpine Bank.
  • “The changes to the board support the vision of Alpine Bank as we continue to operate as a forward thinking, independent, community focused, Colorado bank,” said Jammaron.
  • Gardey joined Alpine Bank in 1989 and has served the bank in various finance, accounting, and audit roles.
  • Additional background on the outgoing board members:
    John Cooper got his start at Alpine Bank in Snowmass Village in 1979, and he was appointed to the board of directors that same year.

Alpine Immune Sciences Shares Updated Clinical Data from Povetacicept in IgA Nephropathy

Retrieved on: 
Wednesday, April 10, 2024
Health, Other Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, FDA, Congress, Immunoglobulin G, ALPN, University, Glomerular filtration rate, Proteinuria, Survival, Cytokine, MD, Hematuria, UPCR, Webcast, Immunoglobulin A, EGFR, Disease, Nephrology, Patient, WCN, Alpine, Inflammation, Multimedia, Infection, Biomarker, Exhibition, University of Leicester, Autoimmunity, BAFF, Pharmaceutical industry

Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today shared updated clinical data for povetacicept in IgA nephropathy (IgAN) which will be presented as a late breaking poster at the World Congress of Nephrology (WCN) April 13-16, 2024 in Buenos Aires, Argentina.

Key Points: 
  • Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today shared updated clinical data for povetacicept in IgA nephropathy (IgAN) which will be presented as a late breaking poster at the World Congress of Nephrology (WCN) April 13-16, 2024 in Buenos Aires, Argentina.
  • RUBY-3 is a multiple ascending dose, multi-cohort, open label, phase 1b/2a study of povetacicept in autoimmune glomerulonephritis, including IgA nephropathy, where povetacicept is administered subcutaneously (SC) once every four weeks.
  • As of March 01, 2024, 41 patients with IgAN had received povetacicept 80 or 240 mg subcutaneously every 4 weeks.
  • These data strongly support the inhibition of APRIL/BAFF pathways by povetacicept and its efficacy in the treatment of IgAN as well as the need for further clinical development.

Discover Unique, Only-in-Vail Moments this Summer

Retrieved on: 
Wednesday, April 24, 2024
Red Road, Colorado Rockies, Partnership, Municipality, Life, Cooking, Picture Perfect, Philadelphia Orchestra, Betty Ford, Artist-in-residence, News, Colorado Ballet, Animal, Love, Town, American Ballet Theatre, Festival, Amp, Grand, Anschutz Entertainment Group, Calendar, Alpine, EGE, Coffee, Philadelphia Ballet, Nature, Travel, Heart, Foot, Rabbit, Music, Multimedia, Beauty, Rhododendron ferrugineum, Ford Park, Eagle County Regional Airport, Wine, Rocky, Bravo, Barenaked Ladies, Hot Summer Night, Athlete, Dinosaur, AEG, Entertainment

VAIL, Colo., April 24, 2024 /PRNewswire/ -- This summer, discover unique only-in-Vail moments with new events, flights and more.

Key Points: 
  • VAIL, Colo., April 24, 2024 /PRNewswire/ -- This summer, discover unique only-in-Vail moments with new events, flights and more.
  • Exciting news for travelers as Eagle County Regional Airport (EGE) doubles its summer flight routes beginning this June.
  • She will also have a display of images from her internationally acclaimed Red Road Project in the Town's Municipal Building throughout the summer.
  • New this summer, Solaris Plaza will offer brides and grooms the opportunity to host their wedding ceremony on the Solaris Lawn.

Paycor Leverages Visier's AI Technology to Empower Businesses to Access Answers About Their Workforce

Retrieved on: 
Wednesday, April 17, 2024
EBay, AI, BASF, Partnership, Panasonic, Visualization, Workflow, HCM, Digital, Privacy, Data collection, Data analysis, Trust, Alpine, Ford Motor Company, Amgen, Retail

VANCOUVER, BC, April 17, 2024 /PRNewswire/ -- Paycor had a vision to be one of the first human capital management (HCM) solutions to bring the power of generative AI for people analytics to their customers. Today, Visier, the globally recognized leader in people analytics and workforce solutions for people-powered business, enabled one of the world's largest-scale deployments of generative AI in HR technology—more than 2.1 million employees of Paycor's customers are now equipped with natural-language answers to people-related questions based on Visier's Vee technology.

Key Points: 
  • The company's embedded analytics business provides the platform and expertise to extend that reach through partnerships like with Paycor.
  • Visier's partnership with Paycor is a prime example of the generative AI vision realized."
  • Paycor announced their generative AI analytics digital assistant powered by Visier in October, underscoring the depth and breadth of the partnership, and the trust in Visier's industry-defining technology.
  • For more information on how to become an Embedded partner to accelerate your generative AI product roadmap, visit https://www.visier.com/embedded/generative-ai/ .

Empowering the Future of Optometry: Axcel Learning Partners with KMK Optometry to Redefine Board Exam Preparation

Retrieved on: 
Thursday, March 28, 2024
Other Professional Services, Optical, General Health, Health, Other Education, Professional Services, Education, Training, Culture, Growth, KMK, Environment, Partnership, NBEO, School, Optometry, Student, Heart, Alpine, Multimedia, Management

Axcel Learning (Axcel), a professional education business backed by Alpine Investors (Alpine), today announced a new partnership with KMK Optometry (KMK), the premier provider of comprehensive optometry board exam test preparation and coaching services.

Key Points: 
  • Axcel Learning (Axcel), a professional education business backed by Alpine Investors (Alpine), today announced a new partnership with KMK Optometry (KMK), the premier provider of comprehensive optometry board exam test preparation and coaching services.
  • For 20 straight years, KMK has been the #1 choice for Optometry board review with the industry’s only fully comprehensive review courses.
  • “Our essence is defined by our commitment to continuous improvement, connection and academic integrity,” said Melissa Cheatham, Co-Founder of KMK.
  • DC Advisory served as the exclusive financial advisor to KMK Optometry.

Alpine Immune Sciences Presents New Translational Data on Povetacicept at the European Lupus Meeting 2024

Retrieved on: 
Thursday, March 21, 2024
Biotechnology, Pharmaceutical, Health, Clinical Trials, IgA nephropathy, Brain, Isoelectric point, WT, Lupus, Patient, Lung, Tissue, Immunoglobulin A, SLE, Doctor of Philosophy, Inflammation, MD, Skin, Alpine, Kidney, Technical, Atomic mass, Autoimmunity, ALPN, Pharmaceutical industry

Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced today that the Company presented new translational data for povetacicept (ALPN-303) at the SLEuro 14th European Lupus Meeting in Bruges, Belgium, March 19-22, 2024.

Key Points: 
  • Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced today that the Company presented new translational data for povetacicept (ALPN-303) at the SLEuro 14th European Lupus Meeting in Bruges, Belgium, March 19-22, 2024.
  • BAFF- and APRIL-related genes are increased in myeloid and B cells in systemic lupus erythematosus (SLE) patients compared to healthy adults.
  • Povetacicept significantly reduces multiple disease parameters in the NZB/W mouse model of lupus, more effectively than WT TACI-Ig or B cell depletion.
  • These findings are particularly intriguing considering that these organs are of particular relevance to our lead indications, systemic lupus erythematosus and IgA nephropathy.

symplr Empowers Healthcare HR Leaders with Actionable Performance Analytics through Expanded Visier Partnership

Retrieved on: 
Wednesday, April 3, 2024
HR, Organization, Workforce management, Talent management, Partnership, Patient, Embedded analytics, Senior, Alpine, Analytics, Management

HOUSTON, April 3, 2024 /PRNewswire-PRWeb/ -- symplr®, a leading provider of enterprise healthcare operations software, today announced an expanded partnership with Visier to empower healthcare HR leaders with improved data and decision-making to engage and retain employees. Through the integration of Visier's embedded analytics into symplr Performance software, healthcare organizations can now gain fresh insights into employee performance and drive strategic workforce management initiatives.

Key Points: 
  • HOUSTON, April 3, 2024 /PRNewswire-PRWeb/ -- symplr ®, a leading provider of enterprise healthcare operations software, today announced an expanded partnership with Visier to empower healthcare HR leaders with improved data and decision-making to engage and retain employees.
  • Through the integration of Visier's embedded analytics into symplr Performance software , healthcare organizations can now gain fresh insights into employee performance and drive strategic workforce management initiatives.
  • "Our work with Visier provides healthcare organizations with actionable insights on their people and programs," said Karissa Fuller, Managing Director, Senior Vice President of Workforce Management at symplr.
  • symplr Performance Analytics tackles this challenge by providing actionable insights at a glance on both individual and team data.

BellSoft releases Alpaquita Containers with Coordinated Restore at Checkpoint support

Retrieved on: 
Thursday, March 14, 2024
JVM, Memory, Coffea liberica, SAN, Java, ARM, Risk-weighted asset, Architecture, GraalVM, Crac, Alpine, API, Use, JDK, OpenJDK, Cryptocurrency

SAN JOSE, Calif., March 14, 2024 /PRNewswire/ -- BellSoft , the OpenJDK vendor that delivers the most complete Java experience, is excited to announce the release of Alpaquita containers with Coordinated Restore at Checkpoint (CRaC) support, rounding up your Java journey with an end-to-end CRaC solution.

Key Points: 
  • SAN JOSE, Calif., March 14, 2024 /PRNewswire/ -- BellSoft , the OpenJDK vendor that delivers the most complete Java experience, is excited to announce the release of Alpaquita containers with Coordinated Restore at Checkpoint (CRaC) support, rounding up your Java journey with an end-to-end CRaC solution.
  • The Coordinated Restore at Checkpoint (CRaC) Project is the most current promising answer.
  • BellSoft's Alpaquita containers are available for JDK 17 and 21 and x86_64 architecture, with ARM support coming later in 2024.
  • "Alpaquita containers are made for Java applications in the cloud, strengthened with CRaC support; they help mitigate the problem of slow startup and warmup," said Alex Belokrlykov, BellSoft's CEO.

Alpine IQ acquires Dispense, unleashing a new era of superior ecommerce and retail marketing capabilities

Retrieved on: 
Tuesday, March 5, 2024
Acquisition, Freedom, ROI, Marketing, Sale, Paschal, Alpine, AIQ, Retail

Looking ahead, Alpine IQ is set to integrate a multitude of innovative features that promise to elevate the digital shopping experience.

Key Points: 
  • Looking ahead, Alpine IQ is set to integrate a multitude of innovative features that promise to elevate the digital shopping experience.
  • The acquisition is not just about enhancing Alpine IQ's current offerings but also about broadening its impact across various sectors.
  • In acquiring Dispense, Alpine IQ celebrates the remarkable journey of a female-led company, grown under the leadership of Kyla Sirni.
  • The company is committed to preserving the Dispense legacy, retaining all staff and further enriching the ecommerce platform with new resources and data analytics capabilities.

Medigus: ParaZero Ramps Up Partnership with US-Based Autonomous Drone OEM Vayu Aerospace Corporation

Retrieved on: 
Thursday, February 22, 2024
ALPP, OEM, EASA, UAS, DCAA, Nitrox, Safety, US-1, Alpine, MDGS, Partnership, Airline

Tel Aviv, Israel, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in electric vehicle charging solutions, advanced medical solutions, and innovative internet technologies, today announced that on February 20, 2024 ParaZero Technologies Ltd. (Nasdaq: PRZO) (“ParaZero”), an aerospace company focused on drone safety systems for commercial drones and urban air mobility aircraft, (18.68% owned by Medigus), announced that it has expanded its collaboration with Vayu Aerospace Corporation ("Vayu"), a US-based drone original equipment manufacturer (OEM) and subsidiary of Alpine 4 Holdings (“Alpine 4”) (Nasdaq: ALPP).

Key Points: 
  • The two companies worked together over the past two years enhancing safety solutions for Vayu’s commercial and military vertical take-off and landing (VTOL) aircraft.
  • With this new collaboration, ParaZero will customize its SafeAir system to be integrated at the design stage of Vayu’s G-1MKII VTOL aircraft.
  • Boaz Shetzer, Chief Executive Officer of ParaZero commented, “We are glad to strengthen our partnership with Vayu, an innovator in autonomous drone technology.
  • The system cuts power to the drone, alerts people on the ground with an audible alarm, and deploys a lightweight parachute, bringing the drone down to the ground in a safe, controlled descent.